| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Kakkis Emil D is a President &CEO at RARE. Recent filings cover 3 purchases and 52 sales.
Our model assigns Kakkis Emil D a strong insider score of 72/100, based on 11 past trades. Over a 12-month horizon, 72.7% of those trades were profitable, with an average 12-month return of +20.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2016 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $67.61 | $1,352,250.81 | -3.9% | |
| Jul 15, 2016 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $50.85 | $1,016,908.50 | -3.8% | |
| May 16, 2016 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $59.95 | $1,199,094.65 | -3.7% | |
| Apr 15, 2016 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $70.33 | $1,406,553.86 | -3.6% | |
| Dec 31, 2015 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $114.52 | $2,290,491.27 | -3.4% | |
| Nov 30, 2015 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $98.27 | $1,965,426.86 | -3.2% | |
| Oct 30, 2015 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $99.57 | $1,991,407.00 | -3.1% |